ACE system will be employed for Pain’s Mab production.

Chromos Molecular Systems inked a cell line development deal with Pain Therapeutics. It will engineer cell lines specific for the expression of a Mab for Pain Therapeutics using the ACE System.

Pain Therapeutics has the right to use the cell lines for scale up and manufacture of the Mab, following the cell line engineering phase of the agreement.

Previous articleAtheroGenics’ Shares Sink after a Disappointing Phase III for Atherosclerosis Drug
Next articleAdventrx Awards Manufacturing Contract to Pharmatek Labs